Fresenius Medical Care AG & Co. KGaA (FMEA) — Capital Reinvestment Ratio

Latest as of March 2026: 0.84x

Fresenius Medical Care AG & Co. KGaA (FMEA) has a Capital Reinvestment Ratio of 0.84x as of March 2026, meaning it reinvests 1% of its operating cash flow (€226.89 Million) in capital expenditures (€190.07 Million). See Fresenius Medical Care AG & Co. KGaA (FMEA) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.84x
Capex / Operating Cash Flow

Operating Cash Flow

€226.89 Million
EUR

Capital Expenditures

€190.07 Million
EUR

Data as of

Mar 2026
Most recent filing

Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio (2016–2025)

This chart tracks Fresenius Medical Care AG & Co. KGaA's Capital Reinvestment Ratio across 10 annual periods. Check Fresenius Medical Care AG & Co. KGaA (FMEA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA (2016–2025)

Year-by-year Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. For live market cap and broader valuation context, see market value of Fresenius Medical Care AG & Co. KGaA.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.34x €2.68 Billion €915.37 Million ▲ +16.5%
2024 0.29x €2.39 Billion €699.36 Million ▲ +12.5%
2023 0.26x €2.63 Billion €684.60 Million ▼ -22.0%
2022 0.33x €2.17 Billion €723.99 Million ▼ -2.7%
2021 0.34x €2.49 Billion €854.36 Million ▲ +38.1%
2020 0.25x €4.23 Billion €1.05 Billion ▼ -43.3%
2019 0.44x €2.57 Billion €1.12 Billion ▼ -14.5%
2018 0.51x €2.06 Billion €1.06 Billion ▲ +19.0%
2017 0.43x €2.19 Billion €944.46 Million ▼ -15.0%
2016 0.51x €1.93 Billion €979.36 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow